DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.
DENTSPLY SIRONA Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$60.73|
|52 Week High||US$42.50|
|52 Week Low||US$69.54|
|1 Month Change||-2.19%|
|3 Month Change||-3.98%|
|1 Year Change||40.22%|
|3 Year Change||61.17%|
|5 Year Change||2.86%|
|Change since IPO||5,730.08%|
Recent News & Updates
|XRAY||US Medical Equipment||US Market|
Return vs Industry: XRAY exceeded the US Medical Equipment industry which returned 36.8% over the past year.
Return vs Market: XRAY exceeded the US Market which returned 35.3% over the past year.
Stable Share Price: XRAY is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: XRAY's weekly volatility (3%) has been stable over the past year.
About the Company
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
DENTSPLY SIRONA Fundamentals Summary
|XRAY fundamental statistics|
Is XRAY overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|XRAY income statement (TTM)|
|Cost of Revenue||US$1.84b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||1.68|
|Net Profit Margin||9.04%|
How did XRAY perform over the long term?See historical performance and comparison
0.7%Current Dividend Yield
Is DENTSPLY SIRONA undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: XRAY ($60.01) is trading below our estimate of fair value ($110.61)
Significantly Below Fair Value: XRAY is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: XRAY is good value based on its PE Ratio (35.6x) compared to the US Medical Equipment industry average (52.3x).
PE vs Market: XRAY is poor value based on its PE Ratio (35.6x) compared to the US market (17.9x).
Price to Earnings Growth Ratio
PEG Ratio: XRAY is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: XRAY is good value based on its PB Ratio (2.6x) compared to the US Medical Equipment industry average (4.8x).
How is DENTSPLY SIRONA forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XRAY's forecast earnings growth (16.8% per year) is above the savings rate (2%).
Earnings vs Market: XRAY's earnings (16.8% per year) are forecast to grow faster than the US market (15% per year).
High Growth Earnings: XRAY's earnings are forecast to grow, but not significantly.
Revenue vs Market: XRAY's revenue (4.8% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: XRAY's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (12.2%).
How has DENTSPLY SIRONA performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: XRAY has high quality earnings.
Growing Profit Margin: XRAY became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: XRAY has become profitable over the past 5 years, growing earnings by 13.6% per year.
Accelerating Growth: XRAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: XRAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (40.5%).
Return on Equity
High ROE: XRAY's Return on Equity (7.3%) is considered low.
How is DENTSPLY SIRONA's financial position?
Financial Position Analysis
Short Term Liabilities: XRAY's short term assets ($1.8B) exceed its short term liabilities ($1.3B).
Long Term Liabilities: XRAY's short term assets ($1.8B) do not cover its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: XRAY's debt to equity ratio (44.3%) is considered high.
Reducing Debt: XRAY's debt to equity ratio has increased from 14.3% to 44.3% over the past 5 years.
Debt Coverage: XRAY's debt is well covered by operating cash flow (32.6%).
Interest Coverage: XRAY's interest payments on its debt are well covered by EBIT (10.4x coverage).
What is DENTSPLY SIRONA current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: XRAY's dividend (0.73%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: XRAY's dividend (0.73%) is low compared to the top 25% of dividend payers in the US market (3.6%).
Stability and Growth of Payments
Stable Dividend: XRAY's dividends per share have been stable in the past 10 years.
Growing Dividend: XRAY's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (24.4%), XRAY's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: XRAY's dividends in 3 years are forecast to be thoroughly covered by earnings (11.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Don Casey (61 yo)
Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since...
CEO Compensation Analysis
Compensation vs Market: Don's total compensation ($USD7.17M) is below average for companies of similar size in the US market ($USD11.36M).
Compensation vs Earnings: Don's compensation has been consistent with company performance over the past year.
Experienced Management: XRAY's management team is considered experienced (3 years average tenure).
Experienced Board: XRAY's board of directors are considered experienced (3.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
DENTSPLY SIRONA Inc.'s employee growth, exchange listings and data sources
- Name: DENTSPLY SIRONA Inc.
- Ticker: XRAY
- Exchange: NasdaqGS
- Founded: 1899
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$13.273b
- Shares outstanding: 218.55m
- Website: https://www.dentsplysirona.com
Number of Employees
- DENTSPLY SIRONA Inc.
- 13320-B Ballantyne Corporate Place
- North Carolina
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/27 22:53|
|End of Day Share Price||2021/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.